Alzheimer’s and Parkinson’s Diseases: Recent DevelopmentsIsrael Hanin, Mitsuo Yoshida, Abraham Fisher This book represents the third in a series of International Conferences related to Alzheimer's (AD) and Parkinson's (PD) diseases. The first one took place in Eilat, Israel, in 1985; and the second one in Kyoto, Japan, in 1989. This book contains the full text of oral and poster presentations from the Third International Conference on Alzheimer's and Parkinson's Diseases: Recent Developments, held in Chicago, Illinois, U.S.A. on November 1-6, 1993. The Chicago Conference was attended by 270 participants. The Scientific Program was divided into nine oral sessions, a keynote presentation, and a poster session. The conference culminated in a Round Table Discussion involving all of the participants in the conference. The four and one-half day meeting served as an excellent medium for surveying the current status of clinical and preclinical developments in AD and PD. There were 59 oral presentations and 93 posters. This book incorporates a majority of both. |
Contents
Measuring Binocular Eye Movement | 13 |
Visual Cognition and Language Function in Alzheimers Disease | 19 |
Variables Affecting Visuospatial Primary Memory Defect in Alzheimers | 25 |
Copyright | |
63 other sections not shown
Other editions - View all
Alzheimer’s and Parkinson’s Diseases: Recent Developments Israel Hanin,Mitsuo Yoshida,Abraham Fisher No preview available - 2013 |
Alzheimer’s and Parkinson’s Diseases: Recent Developments Israel Hanin,Mitsuo Yoshida,Abraham Fisher No preview available - 2013 |
Common terms and phrases
acetylcholine acetylcholinesterase ACh release activity agonists Alzheimer Alzheimer's and Parkinson's Alzheimer's disease amino acid amyloid precursor protein analysis antibody astrocytes B-APP basal forebrain BDNF binding Biochem Brain Res buffer cells cerebral cerebral cortex cholinergic cholinergic neurons clinical cognitive concentrations cortex cortical cultured decrease deficits dementia detected dopamine dopaminergic dose drug effects enzyme estrogen expression factors Figure fraction frontal function gene hippocampus human brain immunoreactivity impaired increase incubated inhibition inhibitor injection lesions levels Lewy body linopirdine mecamylamine membrane memory metabolism mg/kg mitochondrial molecular mouse MPP+ mRNA muscarinic receptors mutation Nagatsu Neurochem neurofibrillary tangles neurons Neurosci neurotrophic nicotinic normal nucleus oxidative Parkinson's disease parkinsonian patients peptide perfusion physostigmine plaques precursor protein processing protease rat brain regions scopolamine senile sequence significant striatum substantia nigra tacrine tissue treatment visual vitro vivo xanomeline